Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (27 ops.)
Latest filing published 19 Mar 2018 for ANI Pharmaceuticals INC, €95k.
Filing timeline
BuySaleDaniel Raynor
Insider track record
Disclosed buys
0
Disclosed sells
27
Signal history
Daniel Raynor: trading record in brief
Daniel Raynor discloses dealings in 2 companies, chiefly Nuco2 Inc /FL and ANI Pharmaceuticals Inc. Between 10 February 2006 and 19 March 2018, the trades on record add up to 33 filings.
Every open-market trade on record is a sale: 27 sales worth €15.6M. The rest of the record consists of 4 share grants and 1 option exercise. In 2018 alone, the filings show no purchases and 6 sales.
The record was last updated on 19 March 2018 with an open-market sale (€95k) in ANI Pharmaceuticals Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel Raynor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
1,902 shares@ US$61.505.3% of flowCommon StockSEC:0001144204-18-015633:0
5,313 shares@ US$60.6214.8% of flowCommon StockSEC:0001144204-18-015633:1
7,928 shares@ US$62.8822.9% of flowCommon StockSEC:0001144204-18-014708:0
14,000 shares@ US$61.8139.7% of flowCommon StockSEC:0001144204-18-014708:1
4,117 shares@ US$62.5911.8% of flowCommon StockSEC:0001144204-18-014708:2
1,919 shares@ US$62.025.4% of flowCommon StockSEC:0001144204-18-014708:3
1,000 shares0Common StockSEC:0001144204-17-018967:0
1,000 shares0Common StockSEC:0001144204-16-093766:0
800 shares0Common StockSEC:0001144204-15-023812:0
200,000 shares@ US$63.00Common StockSEC:0001144204-15-016474:0
12,347 shares@ US$33.85Common StockSEC:0001144204-14-016514:0
19,213 shares@ US$33.85Common StockSEC:0001144204-14-016512:0
1,898 shares@ US$34.35Common StockSEC:0001144204-14-016512:1
21,111 shares@ US$33.89Common StockSEC:0001144204-14-015906:0
8,310 shares0Common StockSEC:0001144204-13-058624:0
11,000 shares@ US$30.00Common Stock, $.001 par valueSEC:0001068854-08-000003:0
6,000 shares@ US$12.50Common Stock, $.001 par valueSEC:0001068854-08-000001:0
2,000 shares@ US$26.22Common Stock, $.001 par valueSEC:0001068854-06-000007:0
2,000 shares@ US$26.05Common Stock, $.001 par valueSEC:0001068854-06-000007:1
3,000 shares@ US$26.64Common Stock, $.001 par valueSEC:0001068854-06-000006:0
2,000 shares@ US$26.38Common Stock, $.001 par valueSEC:0001068854-06-000004:0
1,000 shares@ US$26.75Common Stock, $.001 par valueSEC:0001068854-06-000004:2
2,000 shares@ US$28.61Common Stock, $.001 par valueSEC:0001068854-06-000003:0
2,645 shares@ US$29.50Common Stock, $.001 par valueSEC:0001068854-06-000001:0
1,916 shares@ US$29.40Common Stock, $.001 par valueSEC:0001068854-06-000001:1
25 of 27 declarations
